Cardiac Arrhythmias for USMLE Step 3 & COMLEX-USA Level 3

Mechanisms of Arrhythmias
  • Abnormal Automaticity:
    • Non-pacemaker cells generate spontaneous action potentials, leading to ectopic impulses.
    • Example: Atrial or ventricular premature beats.
  • Triggered Activity:
    • Early or delayed afterdepolarizations initiate abnormal contractions.
    • Example: Torsades de Pointes, often associated with prolonged QT interval.
  • Re-Entry Circuits:
    • Impulses re-enter previously activated tissues due to altered conduction pathways, causing tachyarrhythmias.
    • Example: AV nodal re-entry in Paroxysmal Supraventricular Tachycardia (PSVT).
Supraventricular Arrhythmias
  • Atrial Fibrillation (AF):
    • Irregularly irregular rhythm with absent P waves.
    • Increases thromboembolic risk (managed with anticoagulation, typically DOACs).
    • Rate Control: Beta-blockers or calcium channel blockers.
    • Rhythm Control: Antiarrhythmics (amiodarone) or electrical cardioversion.
  • Atrial Flutter:
    • "Sawtooth" pattern on ECG due to rapid atrial contractions.
    • Treatment: Similar to AF, with a focus on rate control and possible cardioversion.
  • Paroxysmal Supraventricular Tachycardia (PSVT):
    • Sudden-onset tachycardia due to AV nodal re-entry.
    • Acute management: Vagal maneuvers, adenosine; long-term: beta-blockers or ablation.
Ventricular Arrhythmias
  • Premature Ventricular Contractions (PVCs):
    • Isolated, wide QRS complexes without preceding P waves.
    • Often benign but frequent PVCs may require Holter monitoring or treatment with beta-blockers.
  • Ventricular Tachycardia (VT):
    • Series of wide QRS complexes (>100 bpm); can be sustained (>30 sec) or non-sustained.
    • Management: Antiarrhythmics (amiodarone) and cardioversion for hemodynamically unstable VT.
    • Consider implantable cardioverter-defibrillator (ICD) for recurrent VT or structural heart disease.
  • Ventricular Fibrillation (VF):
    • Disorganized, chaotic ventricular activity causing loss of pulse.
    • Immediate defibrillation required for survival.
Bradyarrhythmias
  • Sinus Bradycardia:
    • HR <60 bpm, typically due to medications or increased vagal tone.
    • Symptomatic cases managed with atropine; pacing may be needed if refractory.
  • Atrioventricular (AV) Blocks:
    • First-Degree Block: PR interval >200 ms, no dropped beats.
    • Second-Degree Block:
    • Mobitz I (Wenckebach): Progressive PR prolongation with dropped QRS complexes.
    • Mobitz II: Sudden dropped QRS without prior PR lengthening, often requiring pacemaker.
    • Third-Degree Block: Complete dissociation between atria and ventricles; treated with pacemaker.
Management of Life-Threatening Arrhythmias
  • Advanced Cardiac Life Support (ACLS):
    • VF and pulseless VT: Immediate defibrillation and epinephrine.
    • Bradycardia with hypotension: Atropine, followed by transcutaneous pacing if needed.
  • Torsades de Pointes:
    • Polymorphic VT linked to prolonged QT.
    • Treated with magnesium sulfate and defibrillation if unstable.
  • Antiarrhythmic Drug Classes:
    • Class I: Sodium channel blockers (e.g., procainamide).
    • Class II: Beta-blockers (e.g., metoprolol).
    • Class III: Potassium channel blockers (e.g., amiodarone, sotalol).
    • Class IV: Calcium channel blockers (e.g., verapamil).
Key Points
  • Atrial Fibrillation: Commonly managed with rate control and anticoagulation to reduce stroke risk.
  • Ventricular Tachycardia and Fibrillation: Require immediate cardioversion or defibrillation.
  • Torsades de Pointes: Linked to prolonged QT and managed with magnesium sulfate.
  • Bradyarrhythmias: Advanced AV blocks often need permanent pacemaker placement.
  • ACLS Protocols: Critical in managing VF and pulseless VT to improve survival outcomes.